[go: up one dir, main page]

AU3200197A - New composition and methods - Google Patents

New composition and methods

Info

Publication number
AU3200197A
AU3200197A AU32001/97A AU3200197A AU3200197A AU 3200197 A AU3200197 A AU 3200197A AU 32001/97 A AU32001/97 A AU 32001/97A AU 3200197 A AU3200197 A AU 3200197A AU 3200197 A AU3200197 A AU 3200197A
Authority
AU
Australia
Prior art keywords
methods
new composition
composition
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32001/97A
Inventor
K-H Meyer Zum Buschenfelde
Markus F. Neurath
Sven Pettersson
Warren Strober
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karolinska Innovations AB
Original Assignee
Karolinska Innovations AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations AB filed Critical Karolinska Innovations AB
Publication of AU3200197A publication Critical patent/AU3200197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU32001/97A 1996-06-11 1997-06-11 New composition and methods Abandoned AU3200197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9602300 1996-06-11
SE9602300A SE9602300D0 (en) 1996-06-11 1996-06-11 New composition and methods
PCT/SE1997/001019 WO1997047325A1 (en) 1996-06-11 1997-06-11 New composition and methods

Publications (1)

Publication Number Publication Date
AU3200197A true AU3200197A (en) 1998-01-07

Family

ID=20402958

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32001/97A Abandoned AU3200197A (en) 1996-06-11 1997-06-11 New composition and methods

Country Status (3)

Country Link
AU (1) AU3200197A (en)
SE (1) SE9602300D0 (en)
WO (1) WO1997047325A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425543B2 (en) * 1992-11-16 2008-09-16 The Corporation Of Mercer University Microencapsulated materials and method of making same
US6069008A (en) * 1998-11-25 2000-05-30 Isis Pharmaceuticals Inc. Antisense modulation of NF-kappa-B p65 subunit expression
WO2003006478A1 (en) * 2001-07-10 2003-01-23 Oligos Etc. Inc. Oligonucleotide-containing pharmacological compositions and their use
SE0400399D0 (en) * 2004-02-20 2004-02-20 Index Pharmaceuticals Ab Methods and compositions for the treatment or prevention of secondary ischemic injury
SI2179737T1 (en) 2005-07-01 2014-02-28 Index Pharmaceuticals Ab Modulating responsiveness to steroids
EP2269622B1 (en) * 2005-07-01 2013-12-25 Index Pharmaceuticals AB CpG oligonucleotides used for enhancing steroid activity in a steroid dependent patient
WO2007050034A1 (en) * 2005-10-28 2007-05-03 Index Pharmaceuticals Ab Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
AU2009311748B2 (en) * 2008-11-04 2014-08-21 Index Pharmaceuticals Ab Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells
EP3568477A1 (en) 2017-01-13 2019-11-20 Roche Innovation Center Copenhagen A/S Antisense oligonucleotides for modulating rela expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498147B2 (en) * 1992-05-22 2002-12-24 The Scripps Research Institute Suppression of nuclear factor-κb dependent processes using oligonucleotides
CA2105595A1 (en) * 1992-09-23 1994-03-24 Ramaswamy Narayanan Antisense polynucleotides

Also Published As

Publication number Publication date
SE9602300D0 (en) 1996-06-11
WO1997047325A1 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
AU5752398A (en) Novel ketobenzamides and their use
AU5081298A (en) Surgical method and composition therefor
AU1752697A (en) Deicing composition and method
AU2218297A (en) Deicing composition and method
AU2534397A (en) Deicing composition and method
AU4261697A (en) Compounds and methods
AU3767097A (en) Shampoo compositions and method
AU9790198A (en) Compounds and methods
AU3641597A (en) Methods and compositions comprising r-ibuprofen
AU4907897A (en) Therapeutic liposome composition and method
AU2825597A (en) Elastomer compositions and methods
AU1532297A (en) Starch-emulsifier composition and methods of making
AU4266596A (en) Composition and use
AUPO976797A0 (en) Method and composition (III)
AU2972597A (en) Compositions and uses thereof
AUPO976597A0 (en) Method and composition (I)
AU9301998A (en) Composition and methods using galectin-1
AU4876397A (en) Insecticidal compositions and methods
AU3200197A (en) New composition and methods
AUPN137895A0 (en) Composition and method
GB2318356B (en) Composition and method
AUPO982097A0 (en) Methods and compositions for use therein
AU2980799A (en) Lectomedin materials and methods
AU691690B2 (en) Acrolein-releasing composition and use thereof
AU9374498A (en) Makeup composition and method